JPRN-UMIN000003658已完成2 期
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001) - Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.With moderate or more ascites/pleural effusion 2.Plumonary fibrosis or interstitial pneumonia 3.Cardiac insufficiency or myocardial infarction within six months 4.Active bacterial or fungous infection 5.Uncontrollable diabetes mellitus 6.Psychosis or severe mental disorder 7.Severe drug allergy 8.Simultaneous or metachronous (within 3 years) double cancers, with the exception of intramucosal tumor curable with local therapy 9.Previous chemotherapy or radiotherapy against any other malignancies within 3 years 10.Gemcitabine chemotherapy but with the permission over 6 months after adjuvant chemotherapy 11.Previous therapy against pancreatic cancer 12.With CNS metastasis 13.Pregnant, lactating women or women of childbearing potential 14.Men who want to get partner pregnant 15.Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
进行中（未招募）
1 期
Full-dose single-agent chemotherapy (gemcitabine) or reduced-dose combination chemotherapy as first palliative treatment for fragile patients with advanced pancreatic cancer.Pancreatic CancerEUCTR2021-005067-52-DKAalborg University Hospital, Department of Oncology100
已完成
2 期
A randomized phase II study of Gemcitabine or Gemcitabine + S-1 as adjuvant chemotherapy for resected biliary tract cancerBiliary tract cancer (intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, gallbladder carcinoma)JPRN-UMIN000007244Adjuvant Therapy for BTC Research Group130
已完成
2 期
Phase II trial of gemcitabine monotherapy in the third or further line for pretreated patients with advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000017791Dept.Repiratory Medicine, Osaka Police Hospital21
未知
2 期
Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).on small cell lung cancerJPRN-UMIN000000547Kyoto Thoracic Oncology Research Group (KTORG)76
已完成
2 期
Randomized phase II study comparing Gemcitabine versus TS-1 for advanced bile duct cancerAdvanced bile duct cancerJPRN-UMIN000001595Osaka International Cancer Institute Department of Hepatobiliary and pancreatic Oncology110